Clinical Trials on Locally Advanced or Metastatic Melanoma in France
Total 437 results
-
Hospices Civils de LyonUnknownMetastatic or Locally Advanced Solid TumorsFrance
-
Pierre Fabre MedicamentTerminatedLocally Advanced or Metastatic Solid TumorsFrance, Spain
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
Institut Paoli-CalmettesSociété Francophone d'Onco-GériatrieUnknownAdvanced or Metastatic NSCLC | Advanced or Metastatic MelanomaFrance
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
Assistance Publique Hopitaux De MarseilleUnknownElderly | Locally Advanced or Metastatic CancerFrance
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Solid TumoursUnited States, Spain, Canada, Korea, Republic of
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
Centre Leon BerardBayerActive, not recruitingMetastatic Cancer | Solid Tumor, Adult | Locally Advanced Solid TumorFrance
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocally Advanced or Metastatic and Unresectable HCCUnited States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
-
Centre Antoine LacassagneRecruitingMetastatic or Locally-advanced Digestive CancerFrance
-
Centre Hospitalier Universitaire DijonRecruitingLocally Advanced or Metastatic Small Bowel AdenocarcinomaFrance
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Bladder Urothelial Carcinoma | Locally Advanced Renal Pelvis Urothelial... and other conditionsUnited States
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
DNA TherapeuticsCompleted
-
Toray Industries, IncCompletedCholangiocarcinoma | Colon Cancer | Locally Advanced or Metastatic Solid CarcinomasFrance, United States
-
Exicure, Inc.TerminatedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Merkel Cell Carcinoma | Advanced or Metastatic Cutaneous Squamous Cell Carcinoma | Advanced or Metastatic Melanoma | Advanced or Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
University Hospital, MontpellierRecruiting
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)France
-
Centre Oscar LambretCanceropôle Nord OuestNot yet recruitingSarcoma Metastatic | Locally Advanced Soft Tissue SarcomaFrance
-
Pierre Fabre MedicamentActive, not recruitingAdvanced or Metastatic Solid TumorsFrance, Spain
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedAdvanced or Metastatic Solid TumorsFrance
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
CHU de ReimsCompletedMetastatic MelanomaFrance
-
Nantes University HospitalUMR892Completed
-
Pierre Fabre MedicamentBiotrialActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
Pierre Fabre MedicamentBiotrialCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic MelanomaFrance
-
Assistance Publique Hopitaux De MarseilleCompletedMetastatic MelanomaFrance
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Centre Hospitalier Universitaire de NīmesCompletedMetastatic MelanomaFrance
-
University Hospital, MontpellierSaint-Louis Hospital, Paris, FranceCompleted
-
Hospices Civils de LyonCompletedMetastatic MelanomaFrance
-
Incyte CorporationCompletedMetastatic Melanoma | Unresectable Melanoma | Metastatic Urothelial Cancer | Metastatic Non-small Cell Lung Cancer | Locally Advanced Renal Cell Carcinoma | Locally Advanced Urothelial Cancer | Metastatic Clear-Cell Renal Cell CarcinomaFrance, Spain, United States, Italy, Austria, Romania, Poland, Hungary
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPatients With Advanced or Metastatic Solid TumorsFrance
-
Hospices Civils de LyonUnknown
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Institut BergoniéMinistry of Health, France; PharmaMarTerminatedAdult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated LiposarcomaFrance
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic (Stage IV) MelanomaFrance
-
Centre Hospitalier Universitaire de NiceRecruitingMetastatic MelanomaFrance
-
Anaveon AGRecruitingAdvanced Solid Tumor | Metastatic Melanoma | Melanoma (Skin) | Cutaneous Melanoma | Adult DiseaseUnited States, Spain, Germany, France, Italy
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore